Phase 4, Open Label, Multicentre, 2 Year Safety Study of Lisdexamfetamine Dimesylate in Children/Adolescents With ADHD (SPD489-404)
This study is not yet open for participant recruitment.
Verified August 2011 by Maastricht University Medical Center
Sponsor:
Maastricht University Medical Center
Collaborator:
Shire Development LLC
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01413165
First received: August 9, 2011
Last updated: NA
Last verified: August 2011
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |